{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:16:06Z","timestamp":1792782966656,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T00:00:00Z","timestamp":1462492800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T00:00:00Z","timestamp":1462492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Adele McKinnon Research Fund for Breast Cancer-Related Lymphedema"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA139118"],"award-info":[{"award-number":["R01CA139118"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA089393"],"award-info":[{"award-number":["P50CA089393"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s10549-016-3821-0","type":"journal-article","created":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T04:21:26Z","timestamp":1462508486000},"page":"229-240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema"],"prefix":"10.1007","volume":"157","author":[{"given":"Fangdi","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa N.","family":"Skolny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meyha N.","family":"Swaroop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupendra","family":"Rawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl L.","family":"Brunelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia L.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alphonse G.","family":"Taghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,6]]},"reference":[{"key":"3821_CR1","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/S1053-4296(03)00038-9","volume":"13","author":"AL Cheville","year":"2003","unstructured":"Cheville AL, McGarvey CL, Petrek JA et al (2003) The grading of lymphedema in oncology clinical trials. Semin Radiat Oncol 13:214\u2013225","journal-title":"Semin Radiat Oncol"},{"key":"3821_CR2","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1200\/JCO.2008.18.3517","volume":"27","author":"YC Shih","year":"2009","unstructured":"Shih YC, Xu Y, Cormier JN et al (2009) Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 27:2007\u20132014","journal-title":"J Clin Oncol"},{"key":"3821_CR3","doi-asserted-by":"publisher","first-page":"E220","DOI":"10.1188\/14.ONF.E220-E237","volume":"41","author":"M Burckhardt","year":"2014","unstructured":"Burckhardt M, Belzner M, Berg A et al (2014) Living with breast cancer-related lymphedema: a synthesis of qualitative research. Oncol Nurs Forum 41:E220\u2013E237","journal-title":"Oncol Nurs Forum"},{"key":"3821_CR4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1188\/14.ONF.473-483","volume":"41","author":"LS Jammallo","year":"2014","unstructured":"Jammallo LS, Miller CL, Horick NK et al (2014) Factors associated with fear of lymphedema after treatment for breast cancer. Oncol Nurs Forum 41:473\u2013483","journal-title":"Oncol Nurs Forum"},{"key":"3821_CR5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1634\/theoncologist.2012-0387","volume":"18","author":"J O\u2019Toole","year":"2013","unstructured":"O\u2019Toole J, Jammallo LS, Miller CL et al (2013) Screening for breast cancer-related lymphedema: the need for standardization. Oncologist 18:350\u2013352","journal-title":"Oncologist"},{"key":"3821_CR6","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","volume":"14","author":"T DiSipio","year":"2013","unstructured":"DiSipio T, Rye S, Newman B et al (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14:500\u2013515","journal-title":"Lancet Oncol"},{"key":"3821_CR7","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1245\/s10434-009-0452-2","volume":"16","author":"RJ Tsai","year":"2009","unstructured":"Tsai RJ, Dennis LK, Lynch CF et al (2009) The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol 16:1959\u20131972","journal-title":"Ann Surg Oncol"},{"key":"3821_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1089\/lrb.2005.3.208","volume":"3","author":"JM Armer","year":"2005","unstructured":"Armer JM, Stewart BR (2005) A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population. Lymphat Res Biol 3:208\u2013217","journal-title":"Lymphat Res Biol"},{"key":"3821_CR9","first-page":"2","volume":"34","author":"BH Cornish","year":"2001","unstructured":"Cornish BH, Chapman M, Hirst C et al (2001) Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology 34:2\u201311","journal-title":"Lymphology"},{"key":"3821_CR10","first-page":"18","volume":"41","author":"S Hayes","year":"2008","unstructured":"Hayes S, Janda M, Cornish B et al (2008) Lymphedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence, and identifiable risk factors. Lymphology 41:18\u201328","journal-title":"Lymphology"},{"key":"3821_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10549-012-2111-8","volume":"135","author":"M Ancukiewicz","year":"2012","unstructured":"Ancukiewicz M, Miller CL, Skolny MN et al (2012) Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology. Breast Cancer Res Treat 135:145\u2013152","journal-title":"Breast Cancer Res Treat"},{"key":"3821_CR12","doi-asserted-by":"publisher","first-page":"5666","DOI":"10.1200\/JCO.2008.19.0850","volume":"26","author":"ED Paskett","year":"2008","unstructured":"Paskett ED (2008) Breast cancer-related lymphedema: attention to a significant problem resulting from cancer diagnosis. J Clin Oncol 26:5666\u20135667","journal-title":"J Clin Oncol"},{"key":"3821_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1081\/CNV-48707","volume":"23","author":"JM Armer","year":"2005","unstructured":"Armer JM (2005) The problem of post-breast cancer lymphedema: impact and measurement issues. Cancer Invest 23:76\u201383","journal-title":"Cancer Invest"},{"key":"3821_CR14","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1002\/cncr.27467","volume":"118","author":"SC Hayes","year":"2012","unstructured":"Hayes SC, Johansson K, Stout NL et al (2012) Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care. Cancer 118:2237\u20132249","journal-title":"Cancer"},{"key":"3821_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1365-2354.2009.01141.x","volume":"20","author":"N Devoogdt","year":"2011","unstructured":"Devoogdt N, Van Kampen M, Christiaens MR et al (2011) Short- and long-term recovery of upper limb function after axillary lymph node dissection. Eur J Cancer Care (Engl) 20:77\u201386","journal-title":"Eur J Cancer Care (Engl)"},{"key":"3821_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1524-4741.2009.00855.x","volume":"16","author":"LK Helyer","year":"2010","unstructured":"Helyer LK, Varnic M, Le LW et al (2010) Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients. Breast J 16:48\u201354","journal-title":"Breast J"},{"key":"3821_CR17","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/bjs.5711","volume":"94","author":"TM Bennett Britton","year":"2007","unstructured":"Bennett Britton TM, Buczacki SJ, Turner CL et al (2007) Venous changes and lymphoedema 4\u00a0years after axillary surgery for breast cancer. Br J Surg 94:833\u2013834","journal-title":"Br J Surg"},{"key":"3821_CR18","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1080\/02841860801961257","volume":"47","author":"IL Nesvold","year":"2008","unstructured":"Nesvold IL, Dahl AA, Lokkevik E et al (2008) Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy. Acta Oncol 47:835\u2013842","journal-title":"Acta Oncol"},{"key":"3821_CR19","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1080\/02841850701305440","volume":"48","author":"F Celebioglu","year":"2007","unstructured":"Celebioglu F, Perbeck L, Frisell J et al (2007) Lymph drainage studied by lymphoscintigraphy in the arms after sentinel node biopsy compared with axillary lymph node dissection following conservative breast cancer surgery. Acta Radiol 48:488\u2013495","journal-title":"Acta Radiol"},{"key":"3821_CR20","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1200\/JCO.2008.16.3725","volume":"26","author":"SA McLaughlin","year":"2008","unstructured":"McLaughlin SA, Wright MJ, Morris KT et al (2008) Prevalence of lymphedema in women with breast cancer 5\u00a0years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26:5213\u20135219","journal-title":"J Clin Oncol"},{"key":"3821_CR21","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s10549-010-1167-6","volume":"125","author":"AG Wernicke","year":"2011","unstructured":"Wernicke AG, Goodman RL, Turner BC et al (2011) A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance. Breast Cancer Res Treat 125:893\u2013902","journal-title":"Breast Cancer Res Treat"},{"key":"3821_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1188\/08.ONF.65-71","volume":"35","author":"RL Thomas-Maclean","year":"2008","unstructured":"Thomas-Maclean RL, Hack T, Kwan W et al (2008) Arm morbidity and disability after breast cancer: new directions for care. Oncol Nurs Forum 35:65\u201371","journal-title":"Oncol Nurs Forum"},{"key":"3821_CR23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/jso.21435","volume":"101","author":"EJ Yang","year":"2010","unstructured":"Yang EJ, Park WB, Seo KS et al (2010) Longitudinal change of treatment-related upper limb dysfunction and its impact on late dysfunction in breast cancer survivors: a prospective cohort study. J Surg Oncol 101:84\u201391","journal-title":"J Surg Oncol"},{"key":"3821_CR24","first-page":"118","volume":"43","author":"JM Armer","year":"2010","unstructured":"Armer JM, Stewart BR (2010) Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months. Lymphology 43:118\u2013127","journal-title":"Lymphology"},{"key":"3821_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10549-015-3357-8","volume":"151","author":"NJ Bundred","year":"2015","unstructured":"Bundred NJ, Stockton C, Keeley V et al (2015) Comparison of multi-frequency bioimpedance with perometry for the early detection and intervention of lymphoedema after axillary node clearance for breast cancer. Breast Cancer Res Treat 151:121\u2013129","journal-title":"Breast Cancer Res Treat"},{"key":"3821_CR26","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1007\/s00520-015-2662-4","volume":"23","author":"KY Karlsson","year":"2015","unstructured":"Karlsson KY, Wallenius I, Nilsson-Wikmar LB et al (2015) Lymphoedema and health-related quality of life by early treatment in long-term survivors of breast cancer. A comparative retrospective study up to 15\u00a0years after diagnosis. Support Care Cancer 23:2965\u20132972","journal-title":"Support Care Cancer"},{"key":"3821_CR27","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ejso.2014.12.006","volume":"41","author":"H Sackey","year":"2015","unstructured":"Sackey H, Johansson H, Sandelin K et al (2015) Self-perceived, but not objective lymphoedema is associated with decreased long-term health-related quality of life after breast cancer surgery. Eur J Surg Oncol 41:577\u2013584","journal-title":"Eur J Surg Oncol"},{"key":"3821_CR28","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.apmr.2013.12.015","volume":"95","author":"A Sagen","year":"2014","unstructured":"Sagen A, Kaaresen R, Sandvik L et al (2014) Upper limb physical function and adverse effects after breast cancer surgery: a prospective 2.5-year follow-up study and preoperative measures. Arch Phys Med Rehabil 95:875\u2013881","journal-title":"Arch Phys Med Rehabil"},{"key":"3821_CR29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ejon.2013.10.006","volume":"18","author":"C Bulley","year":"2014","unstructured":"Bulley C, Coutts F, Blyth C et al (2014) A Morbidity Screening Tool for identifying fatigue, pain, upper limb dysfunction and lymphedema after breast cancer treatment: a validity study. Eur J Oncol Nurs 18:218\u2013227","journal-title":"Eur J Oncol Nurs"},{"key":"3821_CR30","volume-title":"Best practice for the management of lymphoedema. International consensus","author":"Lymphoedema Framework","year":"2006","unstructured":"Framework Lymphoedema (2006) Best practice for the management of lymphoedema. International consensus. London, MEP Ltd"},{"key":"3821_CR31","first-page":"26","volume":"40","author":"T Deltombe","year":"2007","unstructured":"Deltombe T, Jamart J, Recloux S et al (2007) Reliability and limits of agreement of circumferential, water displacement, and optoelectronic volumetry in the measurement of upper limb lymphedema. Lymphology 40:26\u201334","journal-title":"Lymphology"},{"key":"3821_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/jpm5020153","volume":"5","author":"C Brunelle","year":"2015","unstructured":"Brunelle C, Skolny M, Ferguson C et al (2015) Establishing and sustaining a prospective screening program for breast cancer-related lymphedema at the massachusetts general hospital: lessons learned. J Pers Med 5:153\u2013164","journal-title":"J Pers Med"},{"key":"3821_CR33","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S1078-5884(96)80005-0","volume":"12","author":"S Tierney","year":"1996","unstructured":"Tierney S, Aslam M, Rennie K et al (1996) Infrared optoelectronic volumetry, the ideal way to measure limb volume. Eur J Vasc Endovasc Surg 12:412\u2013417","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"3821_CR34","first-page":"77","volume":"30","author":"AW Stanton","year":"1997","unstructured":"Stanton AW, Northfield JW, Holroyd B et al (1997) Validation of an optoelectronic limb volumeter (Perometer). Lymphology 30:77\u201397","journal-title":"Lymphology"},{"key":"3821_CR35","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.critrevonc.2013.05.001","volume":"88","author":"J O\u2019Toole","year":"2013","unstructured":"O\u2019Toole J, Jammallo LS, Skolny MN et al (2013) Lymphedema following treatment for breast cancer: a new approach to an old problem. Crit Rev Oncol Hematol 88:437\u2013446","journal-title":"Crit Rev Oncol Hematol"},{"key":"3821_CR36","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.ijrobp.2010.01.001","volume":"79","author":"M Ancukiewicz","year":"2011","unstructured":"Ancukiewicz M, Russell TA, Otoole J et al (2011) Standardized method for quantification of developing lymphedema in patients treated for breast cancer. Int J Radiat Oncol Biol Phys 79:1436\u20131443","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3821_CR37","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10549-013-2655-2","volume":"140","author":"MC Specht","year":"2013","unstructured":"Specht MC, Miller CL, Russell TA et al (2013) Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression? Breast Cancer Res Treat 140:485\u2013494","journal-title":"Breast Cancer Res Treat"},{"key":"3821_CR38","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10549-015-3408-1","volume":"151","author":"MN Swaroop","year":"2015","unstructured":"Swaroop MN, Ferguson CM, Horick NK et al (2015) Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort. Breast Cancer Res Treat 151:393\u2013403","journal-title":"Breast Cancer Res Treat"},{"key":"3821_CR39","unstructured":"NLN Medical Advisory Committee (2013) Position statement of national lymphedema network: screening and measurement for early detection of breast cancer related lymphedema 2015"},{"key":"3821_CR40","first-page":"381","volume":"4","author":"M Golshan","year":"2006","unstructured":"Golshan M, Smith B (2006) Prevention and management of arm lymphedema in the patient with breast cancer. J Support Oncol 4:381\u2013386","journal-title":"J Support Oncol"},{"key":"3821_CR41","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1007\/s00520-015-2662-4","volume":"23","author":"KY Karlsson","year":"2015","unstructured":"Karlsson KY, Wallenius I, Nilsson-Wikmar LB et al (2015) Lymphoedema and health-related quality of life by early treatment in long-term survivors of breast cancer. A comparative retrospective study up to 15\u00a0years after diagnosis. Support Care Cancer 23:2965\u20132972","journal-title":"Support Care Cancer"},{"key":"3821_CR42","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2522\/ptj.20100167","volume":"92","author":"NL Stout","year":"2012","unstructured":"Stout NL, Pfalzer LA, Springer B et al (2012) Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care. Phys Ther 92:152\u2013163","journal-title":"Phys Ther"},{"key":"3821_CR43","first-page":"29","volume":"125","author":"M Asim","year":"2012","unstructured":"Asim M, Cham A, Banerjee S et al (2012) Difficulties with defining lymphoedema after axillary dissection for breast cancer. N Z Med J 125:29\u201339","journal-title":"N Z Med J"},{"key":"3821_CR44","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3109\/02841860903483676","volume":"49","author":"K Johansson","year":"2010","unstructured":"Johansson K, Branje E (2010) Arm lymphoedema in a cohort of breast cancer survivors 10\u00a0years after diagnosis. Acta Oncol 49:166\u2013173","journal-title":"Acta Oncol"},{"key":"3821_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1006\/jsre.2000.6021","volume":"95","author":"MA Kosir","year":"2001","unstructured":"Kosir MA, Rymal C, Koppolu P et al (2001) Surgical outcomes after breast cancer surgery: measuring acute lymphedema. J Surg Res 95:147\u2013151","journal-title":"J Surg Res"},{"key":"3821_CR46","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/bjs.4835","volume":"92","author":"SJ Pain","year":"2005","unstructured":"Pain SJ, Vowler S, Purushotham AD (2005) Axillary vein abnormalities contribute to development of lymphoedema after surgery for breast cancer. Br J Surg 92:311\u2013315","journal-title":"Br J Surg"},{"key":"3821_CR47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3233\/WOR-2009-0926","volume":"34","author":"E Quinlan","year":"2009","unstructured":"Quinlan E, Thomas-MacLean R, Hack T et al (2009) The impact of breast cancer among Canadian women: disability and productivity. Work 34:285\u2013296","journal-title":"Work"},{"key":"3821_CR48","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1046\/j.1440-1622.2000.01839.x","volume":"70","author":"TL Edwards","year":"2000","unstructured":"Edwards TL (2000) Prevalence and aetiology of lymphoedema after breast cancer treatment in southern Tasmania. Aust N Z J Surg 70:412\u2013418","journal-title":"Aust N Z J Surg"},{"key":"3821_CR49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/028418600750013177","volume":"39","author":"I Tengrup","year":"2000","unstructured":"Tengrup I, Tennvall-Nittby L, Christiansson I et al (2000) Arm morbidity after breast-conserving therapy for breast cancer. Acta Oncol 39:393\u2013397","journal-title":"Acta Oncol"},{"key":"3821_CR50","first-page":"161","volume":"42","author":"JN Cormier","year":"2009","unstructured":"Cormier JN, Xing Y, Zaniletti I et al (2009) Minimal limb volume change has a significant impact on breast cancer survivors. Lymphology 42:161\u2013175","journal-title":"Lymphology"},{"key":"3821_CR51","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1589\/jpts.27.2743","volume":"27","author":"S Buragadda","year":"2015","unstructured":"Buragadda S, Alhusaini AA, Melam GR et al (2015) Effect of complete decongestive therapy and a home program for patients with post mastectomy lymphedema. J Phys Ther Sci 27:2743\u20132748","journal-title":"J Phys Ther Sci"},{"key":"3821_CR52","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1089\/lrb.2011.0007","volume":"9","author":"S Hayes","year":"2011","unstructured":"Hayes S, Di Sipio T, Rye S et al (2011) Prevalence and prognostic significance of secondary lymphedema following breast cancer. Lymphat Res Biol 9:135\u2013141","journal-title":"Lymphat Res Biol"},{"key":"3821_CR53","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s11606-006-0077-0","volume":"22","author":"S Zakaria","year":"2007","unstructured":"Zakaria S, Johnson R, Pockaj BA et al (2007) Breast cancer presenting as unilateral arm edema. J Gen Intern Med 22:675\u2013676","journal-title":"J Gen Intern Med"},{"key":"3821_CR54","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.revmed.2007.02.017","volume":"28","author":"S Vignes","year":"2007","unstructured":"Vignes S, Arrault M, Bonhomme S et al (2007) Upper limb lymphedema revealing breast cancer. Rev Med Interne 28:631\u2013634","journal-title":"Rev Med Interne"},{"key":"3821_CR55","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1200\/JCO.2007.14.4899","volume":"26","author":"SC Hayes","year":"2008","unstructured":"Hayes SC, Janda M, Cornish B et al (2008) Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol 26:3536\u20133542","journal-title":"J Clin Oncol"},{"key":"3821_CR56","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1158\/1055-9965.EPI-09-1245","volume":"19","author":"SA Norman","year":"2010","unstructured":"Norman SA, Localio AR, Kallan MJ et al (2010) Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol Biomarkers Prev 19:2734\u20132746","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3821_CR57","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1111\/j.1365-2702.2007.02187.x","volume":"17","author":"JH Park","year":"2008","unstructured":"Park JH, Lee WH, Chung HS (2008) Incidence and risk factors of breast cancer lymphoedema. J Clin Nurs 17:1450\u20131459","journal-title":"J Clin Nurs"},{"key":"3821_CR58","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.amjsurg.2002.12.003","volume":"187","author":"C Ozaslan","year":"2004","unstructured":"Ozaslan C, Kuru B (2004) Lymphedema after treatment of breast cancer. Am J Surg 187:69\u201372","journal-title":"Am J Surg"},{"key":"3821_CR59","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1177\/0897190012442062","volume":"25","author":"CL Griffiths","year":"2012","unstructured":"Griffiths CL, Olin JL (2012) Triple negative breast cancer: a brief review of its characteristics and treatment options. J Pharm Pract 25:319\u2013323","journal-title":"J Pharm Pract"},{"key":"3821_CR60","first-page":"1","volume":"46","author":"International Society of Lymphology","year":"2013","unstructured":"International Society of Lymphology (2013) The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology 46:1\u201311","journal-title":"Lymphology"},{"key":"3821_CR61","unstructured":"Cancer Therapy Evaluation Program (2006) Common terminology criteria for adverse events, version 3.0. DCTD, NCI, NIH, DHHS"},{"key":"3821_CR62","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1200\/JCO.2007.12.3141","volume":"25","author":"TM Tuttle","year":"2007","unstructured":"Tuttle TM, Habermann EB, Grund EH et al (2007) Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol 25:5203\u20135209","journal-title":"J Clin Oncol"},{"key":"3821_CR63","first-page":"3748","volume":"8","author":"Y Fu","year":"2015","unstructured":"Fu Y, Zhuang Z, Dewing M et al (2015) Predictors for contralateral prophylactic mastectomy in breast cancer patients. Int J Clin Exp Pathol 8:3748\u20133764","journal-title":"Int J Clin Exp Pathol"},{"key":"3821_CR64","first-page":"64","volume":"46","author":"CL Miller","year":"2013","unstructured":"Miller CL, Specht MC, Horick N et al (2013) A novel, validated method to quantify breast cancer-related lymphedema (BCRL) following bilateral breast surgery. Lymphology 46:64\u201374","journal-title":"Lymphology"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3821-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-3821-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3821-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3821-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T09:15:25Z","timestamp":1589706925000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-3821-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,6]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["3821"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-3821-0","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,6]]},"assertion":[{"value":"29 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}